IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
Company Details
- Employees
- 10
- Address
- 4570 Executive Drive,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.iconovir.com
- HQ
- San Diego, California
Iconovir Bio Questions
Iconovir Bio's website is http://www.iconovir.com
Iconovir Bio's LinkedIn profile is https://www.linkedin.com/company/iconovir-bio
Iconovir Bio has
10 employees.
View email and phone details for 10
employees at Iconovir Bio.
Iconovir Bio's industry is
Biotechnology Research
Iconovir Bio's top competitors are
Plus Therapeutics, Inc.,
Adicet Bio, Inc,
76bio, Inc.,
Arcellx,
Imugene Limited,
Imunon,
Windtree Therapeutics, Inc.,
Vida Ventures, Llc,
Chimeric Therapeutics,
Latigo Biotherapeutics, Inc..
Iconovir Bio's categories are Biotechnology Research
